Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2023 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2023 Earnings Call Transcript May 10, 2023

Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.15.

Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics first quarter 2023 financial results conference call and webcast. At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions will follow at that...